Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Phase 2b/3, Multicentre, Randomised, Open, Controlled Study on the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB®) Implantation in Non-Infected Hypotrophic Non-Union Fractures

NCT01756326 is registered in ClinicalTrials.gov with Bone Therapeutics S.A as lead sponsor.

NCT NCT01756326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01756326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Phase 2b/3, Multicentre, Randomised, Open, Controlled Study on the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB®) Implantation in Non-Infected Hypotrophic Non-Union Fractures
Lead sponsor
Bone Therapeutics S.A
Phase
Phase 2/3
Overall status
Terminated
Start date
June 30, 2012
Completion date
April 30, 2019
Enrollment
5 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

long bone non-union